Fate Therapeutics Stock Price. Everything You Need To Know About The Fate Therapeutics Stock!
Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. The company is headquartered in San Diego, California and currently employs 551 full-time employees. The company went IPO on 2013-10-01. The firm is focused on developing a pipeline of programmed cellular immunotherapies for patients with cancer and autoimmune disorders. The company uses human induced pluripotent stem cells (iPSCs) generated from its iPSC product platform to create genetically engineered, clonal master iPSC lines having preferred biological properties. The firm is advancing a pipeline of iPSC-derived, chimeric antigen receptor (CAR)-targeted natural killer (NK) and T-cell product candidates. The firm’s product pipeline includes FT576, FT819, FT825 and FT522. Its FT576, is an iPSC-derived, B-cell maturation antigen (BCMA)-targeted CAR NK cell product candidate for the treatment of multiple myeloma. Its FT819, is an iPSC-derived CAR T-cell therapy candidate, which is in Phase I study for the treatment of adult patients with relapsed / refractory B-cell malignancies, including B-cell lymphoma and chronic lymphocytic leukemia.
Fate Therapeutics Stock Price. Everything You Need To Know About The Fate Therapeutics Stock! performance
- Employees 551
- Company HQ San Diego
- Website https://fatetherapeutics.com/
- FATE Asset Type Common Stock
- FATE Market Capitalization 516.6M
- Earnings Per Share -1.64
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth 0
Are you a retail investor from Malaysia, Thailand, Indonesia, or Vietnam looking to invest in promising stocks? Look no further than Fate Therapeutics! As a leading content marketing expert at Zorion, I am excited to provide you with valuable insights on how to invest in this flourishing stock from the comfort of your own home. Fate Therapeutics is a biopharmaceutical company specializing in the development of therapies for patients with severe diseases. Their innovative approach to cell therapy has garnered much attention and investor interest. So, how can you invest in Fate Therapeutics from Malaysia, Thailand, Indonesia, or Vietnam? First, ensure that you have access to Zorion’s investment platform. Sign up for an account and complete the necessary verification processes. Once you are on the platform, you can explore the available investment options, including Fate Therapeutics. Next, conduct thorough research on Fate Therapeutics to understand their business model, pipeline of products, and financial performance. Zorion provides investment insights and recommendations, allowing you to make informed decisions about your investments. To further enhance your investment knowledge, take advantage of the various resources and educational materials offered on Zorion’s platform. Access tutorials, articles, and webinars that delve into the world of stock investing and highlight the potential of Fate Therapeutics. Once you feel confident in your understanding of Fate Therapeutics and its potential, allocate the desired amount of investment capital. Zorion’s platform allows you to invest in real US stocks and Pre-IPO companies with ease, making it accessible for retail investors from Malaysia, Thailand, Indonesia, and Vietnam. Investing in the stock market can be a lucrative endeavor, and Fate Therapeutics presents an exciting opportunity for investors. With Zorion’s comprehensive platform and investment insights, you can confidently navigate the market and make informed decisions about your investments. Start your journey today and seize the potential of Fate Therapeutics!
